Jamal Mahajna
- Pharmacology top 1%
- Fungal Biology and Applications 21
- Phytochemistry and Bioactivity Studies 4
-
- Medicinal plant effects and applications 7
- Pharmacology top 2%
- Fungal Biology and Applications 21
- Phytochemistry and Bioactivity Studies 4
- Biochemistry top 5%
- Plant Science top 5%
-
- Chronic Myeloid Leukemia Treatments 10
-
- Chronic Lymphocytic Leukemia Research 8
-
- Sesquiterpenes and Asteraceae Studies 5
-
- PI3K/AKT/mTOR signaling in cancer 4
- Phytochemical compounds biological activities 4
- Co-authors
- Solomon P. WasserBen-Zion ZaidmanMohammed S. Ali-ShtayehZohara YanivAbraham Z. ReznickCvetomir M. DenchevRachel AmirEviatar Nevo
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Journal of Bacteriology (1 paper)International Journal of Molecular Sciences (4 papers)
- Partner nations
- IsraelPalestinian TerritoryBulgaria
In The Last Decade
Jamal Mahajna
57 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 107
- Pharmacology 676
- Complementary and alternative medicine 270
- Pharmacology 245
- Biochemistry 159
- Plant Science 523
Countries citing papers authored by Jamal Mahajna
This map shows the geographic impact of Jamal Mahajna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Mahajna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Mahajna more than expected).
Fields of papers citing papers by Jamal Mahajna
This network shows the impact of papers produced by Jamal Mahajna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Mahajna. The network helps show where Jamal Mahajna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jamal Mahajna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 12 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 5 | |
| 6 | 2021 | 10 | |
| 7 | 2019 | 32 | |
| 8 | 2016 | 20 | |
| 9 | 2012 | 14 | |
| 10 | 2012 | 76 | |
| 11 | 2012 | 5 | |
| 12 | 2011 | 17 | |
| 13 | 2011 | 5 | |
| 14 | 2010 | 20 | |
| 15 | 2008 | 50 | |
| 16 | 2008 | 14 | |
| 17 | 2006 | 15 | |
| 18 | 2006 | 19 | |
| 19 | 2005 | 351 | |
| 20 | 1997 | 10 |
About Jamal Mahajna
Jamal Mahajna is a scholar working on Pharmacology, Complementary and alternative medicine and Hematology, having authored 57 papers that have together received 1.7k indexed citations. Recurring topics across this work include Fungal Biology and Applications (21 papers), Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Medicinal plant effects and applications (7 papers), Sesquiterpenes and Asteraceae Studies (5 papers), Phytochemistry and Bioactivity Studies (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Phytochemical compounds biological activities (4 papers). The work is most often cited by research in Pharmacology (676 citations), Complementary and alternative medicine (270 citations) and Pharmacology (245 citations). Jamal Mahajna has collaborated with scholars based in Israel, Palestinian Territory and Bulgaria. Frequent co-authors include Solomon P. Wasser, Ben-Zion Zaidman, Mohammed S. Ali-Shtayeh, Zohara Yaniv, Abraham Z. Reznick, Cvetomir M. Denchev, Rachel Amir, Eviatar Nevo, Eran Ben‐Arye and Eviatar Nevo. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Bacteriology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.